Last reviewed · How we verify
NCT04235920
Cognitive Impairment and Outcome of Acute Ischemic Stroke.
trial testing Montreal Cognitive Assessment (MoCA) in Ischemic Stroke in 150 participants. Completed in 31 March 2019.
31 January 2019
Quick facts
| Lead sponsor | Mansoura University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 October 2017 |
| Primary completion | 31 January 2019 |
| Estimated completion | 31 March 2019 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Montreal Cognitive Assessment (MoCA)
Conditions studied
- Ischemic Stroke — all drugs for Ischemic Stroke →
- Cognitive Impairment — all drugs for Cognitive Impairment →
- Outcome, Fatal — all drugs for Outcome, Fatal →
Sponsor
Mansoura University Hospital
Who can join
18 and older, any sex, with Ischemic Stroke or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to assess the use of ASPECTS and stroke biomarkers to predict the outcome and cognitive impairment in acute ischemic stroke.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Predictive Value of the Alberta Stroke Program Early CT Score (ASPECTS) in the Outcome of the Acute Ischemic Stroke and Its Correlation with Stroke Subtypes, NIHSS, and Cognitive Impairment.
Esmael A, Elsherief M, Eltoukhy K. · · 2021 · cited 19× · PMID 33575025 · DOI 10.1155/2021/5935170
Verify or expand the search:
- PubMed search for NCT04235920
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Montreal Cognitive Assessment (MoCA)
Trials testing the same drug.
- NCT07336992 — Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: · Phase 3 · not yet recruiting
- NCT07074028 — Characterization and Longitudinal Monitoring of Muscular Phenotype in Patients Admitted to Intensive Care for Sepsis · NA · recruiting
- NCT06140212 — Exploring the Relationship Between ICOPE Framework and Frailty Among Community-dwelling Elderly Individuals · completed
- NCT05708001 — Improvement of Memory in Mild Cognitive Impairment · NA · recruiting
- NCT06160700 — Serial Testing To Assess Cognitive Function In Cancer · terminated
Other recruiting trials for Ischemic Stroke
Currently open trials in the same condition.
- NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
- NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
- NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
- NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
- NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting
Other Mansoura University Hospital trials
Trials by the same sponsor.
- NCT05936528 — Lactoferrin Use in ICU Patients · Phase 4 · not yet recruiting
- NCT07442617 — Bridging the Gap Between Prescription and Practice: Impact of Nurse-Led Inhaler Education · NA · completed
- NCT07422415 — Effects of E-Cigarette Use Among Young Egyptian Adults · completed
- NCT07122245 — Demographics of Lung Cancer in Females · recruiting
- NCT06917222 — Slide Tracheoplasty Versus Tracheal Resection Anastomosis in Acquired Tracheal Stenosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04235920 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mansoura University Hospital
- Last refreshed: 23 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04235920.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing